ASH 2024 Wrap-Up: Transformative Therapies and Hematology’s Future

The ASH 2024 wrap-up is here! We’re spotlighting the most impactful developments, including menin inhibitors redefining AML treatment, promising gene-editing therapies for sickle cell disease, and next-gen CAR-T advances. Don’t miss this final episode!

Like what you hear? Download Curie from the App store for personalized insights.